CO 027: PROPOSED METHODS AND ESPECIALLY STEM CELLS AS POTENTIAL REPLACEMENT METHODS TO STUDY HUMAN PATHOLOGIES

Excerpt:


J Pharm Pharmacogn Res 2(Suppl. 1): S15, 2014 Special supplement with the abstract book of LATINFARMA 2013 Oral Communication CO 027: PROPOSED METHODS AND ESPECIALLY STEM CELLS AS POTENTIAL REPLACEMENT METHODS TO STUDY HUMAN PATHOLOGIES Bercovier H. Head of the National Committee for Animal Experimentation and Hebrew University of Jerusalem, Israel. Abstract Ex vivo experiments, … Continue reading CO 027: PROPOSED METHODS AND ESPECIALLY STEM CELLS AS POTENTIAL REPLACEMENT METHODS TO STUDY HUMAN PATHOLOGIES

J Pharm Pharmacogn Res 2(Suppl. 1): S15, 2014

Special supplement with the abstract book of LATINFARMA 2013

Oral Communication

CO 027: PROPOSED METHODS AND ESPECIALLY STEM CELLS AS POTENTIAL REPLACEMENT METHODS TO STUDY HUMAN PATHOLOGIES

Bercovier H.

Head of the National Committee for Animal Experimentation and Hebrew University of Jerusalem, Israel.
Abstract

Ex vivo experiments, Phase 0, computational modeling, fMRI on Human and Stem Cells studies have been presented as potential replacement methods for animal experimentation. Many paradoxes are not often envisaged such as the following statement as an example: “instead of using living animals, certain experiments can be carried out on tissue samples in vitro. However the ex vivo preparations cannot regenerate, so they must be acquired by killing animals. Legally, killing an animal to obtain tissue samples is not considered an animal experiment (therefore reducing artificially the number of animal experimentations!!!), even if the animal in question is a vertebrate. In contrast, it is regarded as an animal experiment to anesthetize a vertebrate, make observations while the animal is under anesthesia and then to kill the animal by increasing the dose of anesthetic”. The replacement of in vivo experiments with in vitro methods does not reduce significantly at first the number of research animals that are killed. On the contrary, the limited survival time of brain slices, for example, restricts the amount of data that can be obtained from a single experiment. We will further discuss additional replacement methods and evaluate them in the light of new molecular tools and common sense.

Toxicity evaluation of Ruta angustifolia leaves ethanolic extract
J. Pharm. Pharmacogn. Res., vol. 11, no. 3, pp. 437-447, May-June 2023. DOI: https://doi.org/10.56499/jppres23.1609_11.3.437 Original Article Acute and repeated dose 28-day oral toxicity of Ruta angustifolia Pers. leaves ethanolic extract in Wistar rats [Toxicidad oral aguda y por dosis repetidas durante 28 días del extracto etanólico de hojas de Ruta angustifolia Pers. en ratas Wistar] Tutik … Continue reading Toxicity evaluation of Ruta angustifolia leaves ethanolic extract
Adolescents in Indonesia and COVID-19 pandemic
J. Pharm. Pharmacogn. Res., vol. 11, no. 3, pp. 426-436, May-June 2023. DOI: https://doi.org/10.56499/jppres22.1560_11.3.426 Original Article Perception, mental health, and social media exposure on adolescents in Indonesia during COVID-19 pandemic [Percepción, salud mental y exposición a los medios sociales en adolescentes de Indonesia durante la pandemia de COVID-19] Efa Nugroho1*, Alfiana Ainun Nisa1, Widya Hary Cahyati1, … Continue reading Adolescents in Indonesia and COVID-19 pandemic
Decaffeinated green tea and coffee extracts and metabolic syndrome
J. Pharm. Pharmacogn. Res., vol. 11, no. 3, pp. 414-425, May-June 2023. DOI: https://doi.org/10.56499/jppres23.1593_11.3.414 Original Article Decaffeinated green tea and green coffee extracts as metformin’s add-on enhance metabolic syndrome risk factors and improve the cardiac insulin-gene-related pathway [Extractos de té verde y café verde descafeinados como complemento de la metformina mejoran los factores de riesgo del … Continue reading Decaffeinated green tea and coffee extracts and metabolic syndrome

© 2013-2020 by the authors; licensee JPPRes, Antofagasta, Chile. This journal is an open-access journal distributed under the terms and conditions of the Creative Commons Attribution license-Non Commercial 4.0 international. The content on this site is intended for health professionals. If you are not a health professional, please talk to your doctor about any doubts or concerns regarding your health

Made with ♥ by AVAGAX Studio